Literature DB >> 9778075

Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke.

G P Samsa1, D B Matchar, L Goldstein, A Bonito, P W Duncan, J Lipscomb, C Enarson, D Witter, P Venus, J E Paul, M Weinberger.   

Abstract

BACKGROUND: Patient beliefs, values, and preferences are crucial to decisions involving health care. In a large sample of persons at increased risk for stroke, we examined attitudes toward hypothetical major stroke. METHODS AND
RESULTS: Respondents were obtained from the Academic Medical Center Consortium (n = 621), the Cardiovascular Health Study (n = 321 ), and United Health Care (n = 319). Preferences were primarily assessed by using the time trade off (TTO). Although major stroke is generally considered an undesirable event (mean TTO = 0.30), responses were varied: although 45% of respondents considered major stroke to be a worse outcome than death, 15% were willing to trade off little or no survival to avoid a major stroke.
CONCLUSIONS: Providers should speak directly with patients about beliefs, values, and preferences. Stroke-related interventions, even those with a high price or less than dramatic clinical benefits, are likely to be cost-effective if they prevent an outcome (major stroke) that is so undesirable.

Entities:  

Mesh:

Year:  1998        PMID: 9778075     DOI: 10.1016/s0002-8703(98)70019-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  28 in total

1.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Patient-reported health preferences of anticoagulant-related outcomes.

Authors:  Ye Wang; Feng Xie; Ming Chai Kong; Lai Heng Lee; Heng Joo Ng; Yu Ko
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 3.  [Value-based medicine in ophthalmology].

Authors:  C Hirneiss; A S Neubauer; C Tribus; A Kampik
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

4.  Attitudes in the general population towards hemi-craniectomy for middle cerebral artery (MCA) infarction. A population-based survey.

Authors:  Anne Klein; Christine Kuehner; Stefan Schwarz
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

Review 5.  How well do guidelines incorporate evidence on patient preferences?

Authors:  Christopher A K Y Chong; Ing-je Chen; Gary Naglie; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2009-04-23       Impact factor: 5.128

6.  Patient perceptions of quality-of-life associated with bilateral visual loss.

Authors:  G C Brown; M M Brown; S Sharma; H C Brown
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

7.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

8.  The burden of age-related macular degeneration: a value-based medicine analysis.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Joshua D Stein; Zachary Roth; Joseph Campanella; George R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

9.  Utility scores for vesicoureteral reflux and anti-reflux surgery.

Authors:  Caleb P Nelson; Jonathan C Routh; Tanya Logvinenko; Ilina Rosoklija; Paul J Kokorowski; Lisa A Prosser; Mark A Schuster
Journal:  J Pediatr Urol       Date:  2015-04-30       Impact factor: 1.830

10.  Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial.

Authors:  Jeffrey L Saver; Jeffrey Gornbein; James Grotta; David Liebeskind; Helmi Lutsep; Lee Schwamm; Phillip Scott; Sidney Starkman
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.